BTMPS
BTMPS is a nicotine receptor (nAChR) antagonist that can lessen the negative effects of morphine on rats[1].
Product Specifications
CAS Number
52829-07-9
UNSPSC
12352005
Hazard Statement
H318, H400, H411
Target
NAChR
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Neurological Disease
Purity
98.0
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(OC1CC(C)(C)NC(C)(C)C1)CCCCCCCCC(OC2CC(C)(C)NC(C)(C)C2)=O
Molecular Formula
C28H52N2O4
Molecular Weight
480.73
Precautions
H318, H400, H411
References & Citations
[1]Brandon J Hall, et al. The use-dependent, nicotinic antagonist BTMPS reduces the adverse consequences of morphine self-administration in rats in an abstinence model of drug seeking. Neuropharmacology. 2011 Sep;61 (4) :798-806.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-B280591-50MG 50 mg
1,4-Bis(2-hydroxyethyl) 2,5-dihydroxy-1,4-benzenedicarboxylate-d8
Sign In for Pricing
View Details